Treatment for urinary incontinence in women
MagCath has raised €208k across 1 funding round from 1 investor, most recently a Seed round in Nov 2016. Based in Denmark. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-11-01 | Seed | €208k |
| SEED Capital |
| View deal → |
